It is the University’s expectation that only those who are well and not presenting with COVID-19 symptoms attend a Monash campus or location. View our latest updates.
Monash BDI Global Change Program.
Discover what sets us apart
$15M Mitochondrial donation clinical trial offers hope to families with genetic Mitochondrial disease.
The Monash Biomedicine Discovery Institute (BDI) is changing the rules in the fight against disease, embracing new perspectives for new solutions. We're part of the Faculty of Medicine, Nursing and Health Sciences.
Home to more than 700 researchers, 120 research groups and 200 international research collaborators, we're one of the largest – and highest quality – research institutes in the southern hemisphere.
With a growing pipeline of biomedical breakthroughs – such as our work with stem cells and immunology – we're accelerating discoveries in the lab into clinical treatments.
Hone your expertise under the guidance of at least two supervisors. Join our growing network of more than 270 PhD students across 100 labs, focused on making novel scientific discoveries.
We're committed to making the discoveries that will relieve the future burden of disease. But we need your help.
Our more than 120 specialised research labs are led by recognised leaders in the biomedical field.
We're making the research discoveries that tackle global health issues.
Humanity continues to face challenges in the fight against disease. Watch our two-minute video to discover what we're doing about it.
Want to research, invest, study, or partner with us? We’d love to hear from you.
Monash BDI general enquiries
T: +61 3 9902 9400
23 Innovation Walk
Clayton, Victoria, 3800
Join the conversation
Be inspired by hearing about the latest biomedical research from scientists at the top of their field. Free and open to all to attend.
A strategic collaboration between Monash Biomedicine Discovery Institute and Peter MacCallum Cancer Centre’s Immunology Program has discovered a novel way in which solid cancers may be made responsive to immunotherapy.
A cancer drug could play an important role in limiting the damaging effects of inflammation in COVID-19 patients, thanks to new research co-led by Hudson Institute of Medical Research, Monash University and the Centenary Institute.
An international team of scientists has developed a method for simultaneously detecting thousands of lipid molecules that are displayed to T cells in the human immune system.
A Cabrini Health-Monash Biomedicine Discovery Institute (BDI) partnership will be using Artificial Intelligence (AI) to develop a method for predicting which bowel cancer patients are at risk of relapse after treatment by surgery.
Monash researchers have developed a framework to predict first, how a cancer will become resistant to a drug, and second - given that everyone is different - what the significant differences are that allow some cancers to resist the drug.